Use Of Nucleosome-Transcription Factor Complexes For Cancer Detection

Patent No. EP3433616 (titled "Use Of Nucleosome-Transcription Factor Complexes For Cancer Detection") was filed by Belgian Volition Sprl on Mar 22, 2017. The application was issued on Jul 24, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLESep 30, 2021CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3433616

BELGIAN VOLITION SPRL
Application Number
EP17712782A
Filing Date
Mar 22, 2017
Status
Patent Maintained As Amended
Jun 20, 2024
Publication Date
Jul 24, 2024